An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Tenofovir in Naive Patients With Chronic Hepatitis b

NCT04157699 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis b

Interventions

DRUG: TDF tablet
DRUG: QL-007

Sponsor

Qilu Pharmaceutical Co., Ltd.